Benzinga | Nov 9, 2021 11:09AM EST

Castle Biosciences Q3 EPS $(0.47) Misses $(0.40) Estimate, Sales $23.48M Beat $22.97M Estimate

Castle Biosciences (NASDAQ:CSTL) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate of $(0.40) by 17.5 percent. This is a 104.35 percent decrease over losses of $(0.23) per share from the same period last year. The company reported quarterly sales of $23.48 million which beat the analyst consensus estimate of $22.97 million by 2.20 percent. This is a 54.27 percent increase over sales of $15.22 million the same period last year.